On Invalid Date, Avanos Medical (NYSE: AVNS) reported Q4 2023 earnings per share (EPS) of $0.23, up 37.84% year over year. Total Avanos Medical earnings for the quarter were $10.50 million. In the same quarter last year, Avanos Medical's earnings per share (EPS) was $0.37.
As of Q2 2024, Avanos Medical's earnings has grown year over year. Avanos Medical's earnings in the past year totalled -$61.80 million.
What is AVNS's earnings date?
Avanos Medical's earnings date is Invalid Date. Add AVNS to your watchlist to be reminded of AVNS's next earnings announcement.
What was AVNS's revenue last quarter?
On Invalid Date, Avanos Medical (NYSE: AVNS) reported Q4 2023 revenue of $173.30 million up 4.57% year over year. In the same quarter last year, Avanos Medical's revenue was $181.60 million.
What was AVNS's revenue growth in the past year?
As of Q2 2024, Avanos Medical's revenue has grown -1.58% year over year. This is 10.98 percentage points lower than the US Medical Devices industry revenue growth rate of 9.4%. Avanos Medical's revenue in the past year totalled $673.30 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.